PON2 Antibodies

Santa Cruz Biotechnology offers a broad range of PON2 monoclonal antibodies for research focused on understanding PON2 protein functions. PON2 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). PON2, or paraoxonase 2, belongs to the paraoxonase family of enzymes, which play essential roles in lipid metabolism and antioxidant defense. PON2 significantly contributes to cellular protection against oxidative stress and inflammation, making it a key focus in studies related to cardiovascular diseases and metabolic disorders. Research has shown that PON2 expression levels vary across different tissues and cell types, suggesting diverse physiological functions. Understanding PON2 regulation and activity provides valuable insights into potential therapeutic strategies for various pathological conditions. PON2 has emerged as a promising target for developing new treatments in cardiovascular and metabolic diseases. Recent studies have highlighted PON2's role in maintaining cellular homeostasis and its potential as a biomarker for disease progression. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of PON2's role in human health and disease development.